Log In
Print
BCIQ
Print
Print this Print this
 

Savene, Totect, dexrazoxane (KDX-0811)

Also known as: formerly Topotect

  Manage Alerts
Collapse Summary General Information
Company Apricus Biosciences Inc.
DescriptionTopoisomerase II inhibitor
Molecular Target Topoisomerase II (TOP2)
Mechanism of ActionTopoisomerase II inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationTissue damage
Indication DetailsPrevent tissue damage following extravasation of chemotherapeutics
Regulatory Designation

Japan - Standard Review (Prevent tissue damage following extravasation of chemotherapeutics)

Partner

BioPro Pharmaceutical Inc.; Clinigen Group plc; Kissei Pharmaceutical Co. Ltd.; Laboratoires Biocodex; Norgine B.V.; SpePharm Holding B.V.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today